Arcturus Therapeutics: Funding, Investors & Team (Oct 2026)
Arcturus Therapeutics is an international biomedical firm in the advanced stages of clinical trials, specializing in the creation of messenger RNA-based drugs for infectious diseases. Additionally, they are dedicated to exploring the potential of treating liver and respiratory rare diseases.
Arcturus Therapeutics has raised $115M across 1 funding round on record, the most recent an undisclosed round of $115M announced in Aug 2023.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Arcturus Therapeutics Company Profile and Key Stats
Latest funding round on record: Aug 2023.
Arcturus Therapeutics Funding Rounds
Arcturus Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Arcturus Therapeutics Funding Compared to Other Biotechnology Startups
Arcturus Therapeutics' latest round of $115M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Arcturus Therapeutics in Biotechnology and San Diego
Companies Similar to Arcturus Therapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Arcturus Therapeutics Funding FAQs
What does Arcturus Therapeutics do?
Arcturus Therapeutics is an international biomedical firm in the advanced stages of clinical trials, specializing in the creation of messenger RNA-based drugs for infectious diseases. Additionally, they are dedicated to exploring the potential of treating liver and respiratory rare diseases.
How much funding has Arcturus Therapeutics raised?
Arcturus Therapeutics has raised $115M across 1 round on record. The most recent is an undisclosed round of $115M announced in Aug 2023.
When did Arcturus Therapeutics last raise funding?
Arcturus Therapeutics' most recent funding round on record is an undisclosed round of $115M, announced in Aug 2023.
Who founded Arcturus Therapeutics?
FundedIQ lists Pad (padmanabh) Chivukula (Founder) at Arcturus Therapeutics.
Where is Arcturus Therapeutics headquartered?
Arcturus Therapeutics is based in San Diego, California, United States.
How many employees does Arcturus Therapeutics have?
Arcturus Therapeutics is in the 101-250 employee band.
How does Arcturus Therapeutics' funding compare to other Biotechnology startups?
Arcturus Therapeutics' latest round of $115M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Arcturus Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Arcturus Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.